Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07460908) titled 'Comparison of Terlipressin Versus Octreotide in Patients With Hepatorenal Syndrome' on March 5.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).

Primary Sponsor: Lahore General Hospital

Condition: Hepatorenal Syndrome

Intervention: Drug: terlipressin

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: May 1, 2025

Target Sample Size: 60

Countries of Recruitment: Pakistan

To know more, visit https://clinicaltrials.gov/study/NCT07460908

Published by HT Digital Content ...